Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
21 Nov 2021	Submitted	Original manuscript
25 May 2022	Reviewed	Reviewer Report - Elizabeth George
10 Jun 2022	Reviewed	Reviewer Report - Robert Flick
26 Jun 2022	Author responded	Author comments - Anabel Franco
Resubmission - Version 2
26 Jun 2022	Submitted	Manuscript version 2
11 Jul 2022	Reviewed	Reviewer Report - Elizabeth George
1 Aug 2022	Reviewed	Reviewer Report - Amgad Rabie
2 Aug 2022	Author responded	Author comments - Anabel Franco
Resubmission - Version 3
2 Aug 2022	Submitted	Manuscript version 3
6 Aug 2022	Reviewed	Reviewer Report - Muslim Syed
26 Aug 2022	Reviewed	Reviewer Report - Anastasia Karachalia-Sandri Karachalia-Sandri
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
8 Sep 2022	Editorially accepted
15 Sep 2022	Article published	10.1186/s13063-022-06722-x

Back to article page